Synthetic MR AB (STU:9480) FCF Yield %: -31.50 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:9480 Synthetic MR AB STU:9480
63 GF Score
Price €0.03
GF Value €0.26
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Synthetic MR AB FCF Yield %?

Synthetic MR AB STU:9480 +3.10% 63 FCF Yield % is -31.50 as of Jul. 15, 2026. GuruFocus rates STU:9480 with a GF Score™ of 63/100 and a GF Value™ of €0.26 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Synthetic MR AB ranks worse than 91.41% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Synthetic MR AB's Trailing 12-Month Free Cash Flow is €-1.61 Mil, and Market Cap is €5.02 Mil. Therefore, Synthetic MR AB's FCF Yield % for today is -31.50%.

The historical rank and industry rank for Synthetic MR AB's FCF Yield % or its related term are showing as below:

STU:9480' s FCF Yield % Range Over the Past 10 Years
Min: -38.98   Med: -0.47   Max: 2.03
Current: -31.5


During the past 13 years, the highest FCF Yield % of Synthetic MR AB was 2.03%. The lowest was -38.98%. And the median was -0.47%.

STU:9480's FCF Yield % is ranked worse than
91.41% of 687 companies
in the Healthcare Providers & Services industry
Industry Median: 1.83 vs STU:9480: -31.50

Synthetic MR AB's FCF Margin % for the quarter that ended in Mar. 2026 was -41.53%.


Synthetic MR AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Synthetic MR AB FCF Yield % Related Terms


Synthetic MR AB FCF Yield % Historical Data

* Premium members only.

The historical data trend for Synthetic MR AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synthetic MR AB FCF Yield % Chart

Synthetic MR AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -5.44 -16.21

Synthetic MR AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.31 -3.09 -13.92 -27.63 -46.53

STU:9480 vs VEEV, BTSG, TEM: FCF Yield % Comparison

For the Health Information Services subindustry, Synthetic MR AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB FCF Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's FCF Yield % falls into.


STU:9480
63GF Score
Synthetic MR AB STU:9480
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synthetic MR AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Synthetic MR AB's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1.232 / 7.600116
=-16.21%

Synthetic MR AB's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.505 * 4 / 4.3415352
=-46.53%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -31.50 mean?
Synthetic MR AB (STU:9480) has a FCF Yield % of -31.50 as of Jul. 15, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Synthetic MR AB and its competitors. According to the industry distribution chart, Synthetic MR AB ranks #628 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 91.4%.
Is Synthetic MR AB's FCF Yield % too high?
Synthetic MR AB's current FCF Yield % is -31.50. Based on the distribution chart, Synthetic MR AB ranks #628 out of 687 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Synthetic MR AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's FCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Synthetic MR AB ranks #628 out of 687 companies for FCF Yield %. This places Synthetic MR AB in the lower half of its industry. The industry median FCF Yield % is 1.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.83, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Synthetic MR AB and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synthetic MR AB's current FCF Yield % is -31.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Based on GuruFocus' analysis, Synthetic MR AB (STU:9480) is currently considered Possible Value Trap. The stock's GF Value™ is €0.26, compared to a current price of €0.03 — trading 89.8% below its estimated fair value. The current FCF Yield % is -31.50. Synthetic MR AB's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Synthetic MR AB (STU:9480), the current FCF Yield % is -31.50 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synthetic MR AB (STU:9480) Overvalued in 2026?

Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued. The current stock price of €0.03 is trading 89.8% below its estimated GF Value™ of €0.26. GuruFocus considers Synthetic MR AB to be Possible Value Trap.

Key valuation signals for STU:9480:

  • FCF Yield %: -31.50
  • GF Value™: €0.26 vs. price of €0.03 (89.8% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the STU:9480 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synthetic MR AB Business Description

Other Exchanges SYNT:Sweden
Address Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
63GF Score

Get the complete analysis for STU:9480

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.26
GF Value